Core Laboratories Stock Forecast, Price & News

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 3 sell ratings, 7 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Core Laboratories stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLB, but not buy additional shares or sell existing shares.
View analyst ratings for Core Laboratories or view top-rated stocks.

Wall Street analysts have given Core Laboratories a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Core Laboratories wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Core Laboratories is scheduled to release its next quarterly earnings announcement on Wednesday, July 28th 2021.
View our earnings forecast for Core Laboratories.

Core Laboratories (NYSE:CLB) announced its quarterly earnings data on Tuesday, April, 20th. The oil and gas company reported $0.15 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.13 by $0.02. The oil and gas company had revenue of $108.40 million for the quarter, compared to the consensus estimate of $112.19 million. Core Laboratories had a net margin of 4.26% and a trailing twelve-month return on equity of 31.69%. Core Laboratories's revenue for the quarter was down 28.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.31 earnings per share.
View Core Laboratories' earnings history.

Core Laboratories' stock was trading at $10.93 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CLB shares have increased by 288.4% and is now trading at $42.45.
View which stocks have been most impacted by COVID-19.

Core Laboratories announced a quarterly dividend on Friday, April 23rd. Investors of record on Monday, May 3rd will be given a dividend of $0.01 per share on Tuesday, May 18th. This represents a $0.04 annualized dividend and a yield of 0.09%. The ex-dividend date is Friday, April 30th.
View Core Laboratories' dividend history.

Core Laboratories pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.09%. Core Laboratories does not yet have a strong track record of dividend growth. The dividend payout ratio of Core Laboratories is 5.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Core Laboratories will have a dividend payout ratio of 2.94% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.
View Core Laboratories' dividend history.

11 analysts have issued 1 year target prices for Core Laboratories' shares. Their forecasts range from $16.00 to $38.00. On average, they expect Core Laboratories' stock price to reach $26.11 in the next year. This suggests that the stock has a possible downside of 38.5%.
View analysts' price targets for Core Laboratories or view top-rated stocks among Wall Street analysts.

60 employees have rated Core Laboratories CEO David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among Core Laboratories' employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Core Laboratories include Subsea 7 (SUBCY), Liberty Oilfield Services (LBRT), Oceaneering International (OII), National Energy Services Reunited (NESR), RPC (RES), NexTier Oilfield Solutions (NEX), ProPetro (PUMP), Helix Energy Solutions Group (HLX), Frank's International (FI), Select Energy Services (WTTR), North American Construction Group (NOA), FTS International (FTSI), Mammoth Energy Services (TUSK), Natural Gas Services Group (NGS) and Ranger Energy Services (RNGR).
View all of CLB's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Core Laboratories' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (11.78%), Earnest Partners LLC (9.26%), Fred Alger Management LLC (6.90%), Massachusetts Financial Services Co. MA (6.41%), Clearbridge Investments LLC (3.70%) and AKO Capital LLP (2.20%). Company insiders that own Core Laboratories stock include Gregory Barry Barnett, Jan Willem Sodderland, Lawrence Bruno and Mark F Elvig.
View institutional ownership trends for Core Laboratories.

CLB stock was sold by a variety of institutional investors in the last quarter, including AKO Capital LLP, Eaton Vance Management, Thrivent Financial for Lutherans, Van ECK Associates Corp, Disciplined Growth Investors Inc. MN, Renaissance Technologies LLC, Tudor Investment Corp Et Al, and Douglas Lane & Associates LLC.
View insider buying and selling activity for Core Laboratories or view top insider-selling stocks.

CLB stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Fred Alger Management LLC, Amundi Asset Management US Inc., Edgestream Partners L.P., Ameriprise Financial Inc., Envestnet Asset Management Inc., BNP Paribas Arbitrage SA, and Dimensional Fund Advisors LP. Company insiders that have bought Core Laboratories stock in the last two years include Gregory Barry Barnett, Jan Willem Sodderland, and Lawrence Bruno.
View insider buying and selling activity for Core Laboratories or or view top insider-buying stocks.

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CLB stock can currently be purchased for approximately $42.45.

Core Laboratories has a market capitalization of $1.97 billion and generates $487.27 million in revenue each year. The oil and gas company earns $-97,640,000.00 in net income (profit) each year or $0.80 on an earnings per share basis.

Core Laboratories employs 3,700 workers across the globe.

Core Laboratories was founded in 1936.

The official website for Core Laboratories is www.corelab.com.

Core Laboratories is headquartered at STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX.

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]